Showing results (171-180 of 242) with videos related to
Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2021
Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover)Shannon L Puhalla, Véronique Diéras, Banu K Arun, et al.Cancers|January 8, 2023
Results of PD-L1 Analysis of Women Treated with Durvalumab in Advanced Endometrial Carcinoma (PHAEDRA)Deborah Smith, Kristy P Robledo, Sonia Yip, et al.Cancer|November 20, 2016
What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data studyBunja J Rungruang, Austin Miller, Thomas C Krivak, et al.Gynecologic Oncology|December 2, 2014
Progression-free survival by local investigator versus independent central review: comparative analysis of the AGO-OVAR16 TrialAnne Floquet, Ignace Vergote, Nicoletta Colombo, et al.Gynecologic Oncology|May 28, 2019
Phase 2 study of anastrozole in recurrent estrogen (ER)/progesterone (PR) positive endometrial cancer: The PARAGON trial - ANZGOG 0903Linda Mileshkin, Richard Edmondson, Rachel L O'Connell, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 28, 2020
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)Natalie Yl Ngoi, Valerie Heong, Samuel Ow, et al.Gynecologic Oncology|August 6, 2021
Tolerability of maintenance olaparib in newly diagnosed patients with advanced ovarian cancer and a BRCA mutation in the randomized phase III SOLO1 trialNicoletta Colombo, Kathleen Moore, Giovanni Scambia, et al.The New England Journal of Medicine|October 23, 2018
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian CancerKathleen Moore, Nicoletta Colombo, Giovanni Scambia, et al.British Journal of Cancer|October 25, 2018
Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapyMichael Friedlander, Ursula Matulonis, Charlie Gourley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2009
Improving cancer outcomes through international collaboration in academic cancer treatment trialsEdward L Trimble, Jeffrey S Abrams, Ralph M Meyer, et al.Pageof 25